Atlas Trials

Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)

Clinical trial NCT05652907 · TERMINATED

Trial details

NCT number
NCT05652907
Sponsor
Quantum Biopharma
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Mast Cell Activation SyndromeMast Cell Activation Disorder Idiopathic
Start date
2023-01-19
Primary completion
2023-05-24
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.